ICAD Meeting Features Wealth of Clinical Trial Information.
HEALTH AND BEAUTY CLOSE-UP-26 August 2008-ICAD Meeting Features Wealth of Clinical Trial Information(C)2008 - CloseUpMedia - newsdesk@closeupmedia.com A hallmark of this year's ICAD meeting was the wealth of new clinical trials information in Alzheimer's Disease (AD). In a release, the Group noted: Years...

The CATIE study: effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.
The conclusions of a highly publicized trial on the use of atypical antipsychotic agents in patients with Alzheimer's disease have caused many clinicians in LTC settings to question their prescribing practices. However, Dr. Rosen believes that the study results ought to be examined further before issuing prescribing recommendations. ...

New Book Links Nerve Disease, Alzheimer's and Fibromyalgia with Diabetes.
Chronic Nerve Pain May Be Successfully Treated by RAISING Blood Sugar Levels RESTON, Va., Jan. 31 /PRNewswire/ -- Millions of people suffer from the chronic pain and complications of autonomic neuropathy, a degenerative nerve disease. A new book suggests that this suffering can be effectively treated by...

The Alzheimer's action plan; the experts' guide to the best diagnosis and treatment for memory problems.
9780312355395 The Alzheimer's action plan; the experts' guide to the best diagnosis and treatment for memory problems. Doraiswamy, P. Murali and Lisa P. Gwyther. St. Martin's Press 2008 470 pages $26.95 Hardcover RC523...

Power3 Medical Products Reports Progress on Its Blood Serum Diagnostic Test for Alzheimer's.
HEALTH AND BEAUTY CLOSE-UP-18 August 2008-Power3 Medical Products Reports Progress on Its Blood Serum Diagnostic Test for Alzheimer's(C)2008 - CloseUpMedia - newsdesk@closeupmedia.com Power3 Medical Products, a proteomics company specializing in the development and commercialization of diagnostic tests for early detection of breast cancer and neurodegenerative diseases, is...

Antidementia drugs may prolong life in Alzheimer's patients: cause and effect are still not proven.
CHICAGO -- Continuous use of antidementia drugs is associated with a decreased risk of death in Alzheimer's patients. Specifically, those who took the medications for more than 70% of the time since being diagnosed with dementia lived an average of 3 years longer than did those who took them...

Antihistamine may slow pace of cognitive decline in Alzheimer's.
CHICAGO -- An off-the-market antihistamine previously shown to slow cognitive decline over 1 year in Alzheimer's patients continued to preserve cognition and memory during a 6-month open-label extension trial. The drug, dimebon, also stabilized cognition in patients who started on it after taking placebo during the original...

Antidementia drugs may prolong life in AD.
CHICAGO--Continuous use of antidementia drugs is associated with a decreased risk of death in Alzheimer's patients. Specifically, those who took the medications for more than 70% of the time since being diagnosed with dementia lived an average of 3 years longer than did those who took them for shorter...

Laptop dementia screener is accurate, faster than MMSE.
CHICAGO -- A quick, computerized screening test for dementia may be one step closer to reality. Researchers at the University of Florida Alzheimer's Center and Research Institute have developed the Dementia Screening Battery, a self-administered test that takes about 15 minutes to complete on a laptop computer....

Trio brings music, camaraderie to Coleman House.
Byline: Susan Nest Once a week, a little girl, her grandmother and a dog visit residents at Coleman House, a senior care residence, in Northboro. Zoe Wolfus, 4, of Shrewsbury, is following in the footsteps of her grandmother, Shirley Pierce of Shrewsbury. "Shirley's...